Treatments
Featured Article
Treating Acute Urinary Tract Infection in Postmenopausal Women
Expert perspective on management and treatment of acute urinary tract infections in postmenopausal women.
Latest News
FDA Approves New Treatment for Onchocerciasis
Moxidectin, a macrocyclic lactone, is an anthelmintic drug that selectively binds to the parasite's glutamate-gated chloride ion channels.
FDA Grant Orphan Drug Status to Brincidofovir for Smallpox
Brincidofovir is the Company's lead candidate, a nucleotide analog that has antiviral activity against variola virus, which causes smallpox.
Treatment for Prosthetic Joint Infections Gets FDA's QIDP Designation
PJI is a challenging complication of joint arthroplasty with few effective treatment options.
Children Typically Have 14 Simple Infections by Age 3 Years
Children experience a median of 14 infections during their first three years of life, though there is large variation in incidence.
First Single-Dose Oral Therapy for Bacterial Vaginosis Launched
In both pivotal trials, a statistically significant greater percentage of treatment patients experienced clinical response vs those treated with placebo at 21 to 30 days following a single dose.
Infection Risk With Second-Generation Disease-Modifying Treatments in MS
Investigators examined the association between infection-related medical encounters and disease-modifying treatments for multiple sclerosis.
FDA Panel Votes on Plazomicin for Complicated UTI, Bloodstream Infections
The Committee voted unanimously (15-0) that substantial evidence on the safety and efficacy of plazomicin was presented for the treatment of cUTI but voted against its use (4-11) for the treatment of bloodstream infections in patients with limited or no treatment options.
Novel Drug Combinations, Dosing Strategies Needed for E faecalis Bloodstream Infections
Review highlights available treatment options and their limitations and provides direction for investigation of future novel combination therapies to further aid in the treatment of Enterococcus faecalis infective endocarditis.
Antiherpetic Medications May Reduce Risk for Dementia
Patients with herpes simplex virus infections may have a 2.56-fold increased risk for developing dementia, and using antiherpetic medications may decrease dementia risk.
Colistin Plus Meropenem Not Superior to Monotherapy for Carbapenem-Resistant Gram-Negative Bacteria
Results strongly support the avoidance of colistin-carbapenem combination therapy for carbapenem-resistant A baumannii infections regardless of the infection source.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Switching to Tenofovir vs Continuing Entecavir in Chronic Hepatitis B
- Increased Need for Antibiotic Stewardship in Outpatient Settings
- Examining the Effects of Nonmedical Exemptions for Vaccinations
- Delays in Lactate Testing Associated With Delayed Antibiotics, Increased Mortality in Sepsis
- Sepsis-3 Septic Shock Criteria vs SIRS to Predict Mortality in Hospitalized Patients
- The Role of Dietary Trehalose in the Clostridium difficile Epidemic
- Delays in Lactate Testing Associated With Delayed Antibiotics, Increased Mortality in Sepsis
- Etiology of Acute Liver Failure Can Yield Surprising Findings
- How Many Chances Are Too Many? Treating Recurrent Infective Endocarditis in IV Drug Users
- Delay of Lactate Draws in Sepsis Ups Risk of In-Hospital Death
- Normal on-Treatment ALT Linked to Reduced Hepatic Events in Hepatitis B
- Parents Say Cancer Prevention Best Reason for HPV Vaccination
- Should Metronidazole Be Recommended for Mild Clostridium difficile Infections?
- Effective Clinical Pharmacist Specialist Management of Direct-Acting Antiviral Treatment for HCV
- Deferred Treatment With Sofosbuvir-Velpatasvir-Voxilaprevir in Chronic HCV
